2025/5/23

Latanoprost API

Secures MFDS Approval in Korea

2025/1/26

Bimatoprost

Obtains CN DS License!

We know Prostaglandin

More than 20 years of experience

Lubiprostone

Latanoprostene Bunod

Bimatoprost

Travoprost

Tafluprost

Latanoprost

Misoprostol

Cloprostenol Sodium

Homeeverlightchemical2026-03-19T14:43:50+08:00

API development and manufacturing

Focus on prostaglandin APIs
Sales are widely distributed over 40 countries in the world

News

US FDA 2025: Everlight Chemical API Plant Passed

everlightchemical2026-03-18T16:22:47+08:002026/03/18|awards|

Join Us – 2025 CPHI In Frankfurt

everlightchemical2025-10-20T14:21:31+08:002025/09/05|exhibition|

Latanoprost API Secures MFDS Approval in Korea

everlightchemical2025-06-10T09:16:29+08:002025/05/23|awards|

Bimatoprost, Obtains CN DS License.

everlightchemical2025-05-23T16:54:08+08:002025/02/27|awards|

Join Us – 2024 CPhI In Milano

everlightchemical2024-08-21T11:47:22+08:002024/08/21|exhibition|

Prostaglandin

Cardiovascular Disease

Cancer Disease

Veterinary

Other APIs

In order to provide you with the best personalized and instant service, this website uses cookies to record and access your browsing information. By using this website, you agree to the technical support of cookies. Accept